LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
Chen. Q Q; Schmidt. A P AP; Anderson. G M GM; Wang. J M JM; Wooters. J J; Oppenheim. J J JJ; Chertov. O O
Key Findings
- LL-37 draws neutrophils, monocytes, and T‑cells toward it (chemotaxis)
- The attraction works through the FPRL1 receptor
- LL-37 causes calcium mobilization in immune cells, which can be blocked by other FPRL1 activators
Practical Outcomes
- This shows LL-37 has immune‑modulating properties beyond killing microbes, but the study doesn’t give dosing or safety info for supplementation. Biohackers should view it as a mechanistic insight rather than a ready‑to‑use protocol, and await more applied research before trying to use LL-37 for health benefits.
Summary
LL-37, a natural peptide made by white blood cells and skin cells, can attract other immune cells like neutrophils, monocytes, and T‑cells by binding to a receptor called FPRL1, and it triggers calcium signals inside those cells.
Abstract
We have previously shown that antimicrobial peptides like defensins have the capacity to mobilize leukocytes in host defense. LL-37 is the cleaved antimicrobial 37-residue, COOH-terminal peptide of hCAP18 (human cationic antimicrobial protein with a molecular size of 18 kD), the only identified member in humans of a family of proteins called cathelicidins. LL-37/hCAP18 is produced by neutrophils and various epithelial cells. Here we report that LL-37 is chemotactic for, and can induce Ca(2+) mobilization in, human monocytes and formyl peptide receptor-like 1 (FPRL1)-transfected human embryonic kidney 293 cells. LL-37-induced Ca(2+) mobilization in monocytes can also be cross-desensitized by an FPRL1-specific agonist. Furthermore, LL-37 is also chemotactic for human neutrophils and T lymphocytes that are known to express FPRL1. Our results suggest that, in addition to its microbicidal activity, LL-37 may contribute to innate and adaptive immunity by recruiting neutrophils, monocytes, and T cells to sites of microbial invasion by interacting with FPRL1.
Study Information
pubmed
2000
2000-10-02T00:00:00.000Z
10.1084/jem.192.7.1069